Noorwegen -
Noors -
Statens legemiddelverk
eligard 45 mg
2care4 aps - leuprorelinacetat - pulver og væske til injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 45 mg
Europese Unie -
Noors -
EMA (European Medicines Agency)
camcevi
accord healthcare s.l.u. - leuprorelin mesilate - prostata neoplasmer - endokrin terapi - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
Noorwegen -
Noors -
Statens legemiddelverk
eligard 22.5 mg
2care4 aps - leuprorelinacetat - pulver og væske til injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 22.5 mg
Europese Unie -
Noors -
EMA (European Medicines Agency)
degarelix accord
accord healthcare s.l.u. - degarelix acetate - prostata neoplasmer - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
Noorwegen -
Noors -
Statens legemiddelverk
fulvestrant ever pharma 250 mg
ever valinject gmbh - fulvestrant - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 250 mg